Patent AnalyticsExaminers
Rankings

Company or institution

4SC AG

51 applicationsfiled 2006 to 2020

Allowance rate
53%
−22 pts vs the USPTO range 40% to 66%
Rejections before allowance
1.9
+0.3 vs the USPTO
Months to first action
20.8 mo
+2.2 vs the USPTO
Needed an RCE
18%
−9 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

C07D Heterocyclic compounds41 apps
A61K Medical preparations6 apps
A61P Therapeutic activity of compounds1 apps
C12Q Measuring or testing processes involving enzymes or nucleic acids1 apps
G01N Investigating or analysing materials1 apps
C07C 1 apps

Art units

162514 apps
162411 apps
16268 apps
16285 apps
16224 apps
16272 apps

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
17048447Combination comprising HDAC inhibitor, LAG-3 inhibitor and a PD-1 inhibitor or PD-L…2020-10-16Abandoned2039.3 mo
17047529PHARMACEUTICAL COMBINATION PRODUCTS COMPRISING A HISTONE DEACETYLASE (HDAC) INHIBIT…2020-10-14Abandoned3126.1 mo
17041703Combination comprising HDAC inhibitor and CD137 agonist for cancer therapy2020-09-25Allowed1036.1 mo
15366580Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15661328Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15895488Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15232484Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15920640Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15184308Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15140133Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock all 51 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in